[Financial Highlights](index=1&type=section&id=Financial%20Highlights) The Group's performance rebounded strongly, with total revenue surging 84.1% to HK$269.02 million and profit for the year soaring to HK$30.67 million, driven by Hong Kong's tourism recovery and improved gross margin Key Financial Indicators for FY2024 | Indicator | 2024 FY | 2023 FY | YoY Change | | :--- | :--- | :--- | :--- | | Revenue (HK$ Thousand) | 269,022 | 146,158 | +84.1% | | Gross Profit (HK$ Thousand) | 234,293 | 121,234 | +93.2% | | Profit for the Year (HK$ Thousand) | 30,674 | 497 | +6071.8% | | Gross Margin (%) | 87.1% | 82.9% | +4.2 percentage points | | Basic Earnings Per Share (HK Cents) | 4.03 | 0.07 | +5657.1% | | Proposed Final Dividend (HK Cents/share) | 2.0 | 1.0 | +100% | - Significant performance growth was primarily attributed to the recovery of inbound tourism and consumer sentiment after the lifting of pandemic-related restrictions, alongside effective sales and marketing resource allocation[89](index=89&type=chunk)[91](index=91&type=chunk) [Consolidated Financial Statements](index=1&type=section&id=Consolidated%20Financial%20Statements) This section presents the Group's detailed financial statements as of March 31, 2024, including the consolidated statement of profit or loss and other comprehensive income and the consolidated statement of financial position, reflecting the company's operating results and financial position [Consolidated Statement of Profit or Loss and Other Comprehensive Income](index=1&type=section&id=Consolidated%20Statement%20of%20Profit%20or%20Loss%20and%20Other%20Comprehensive%20Income) For the year ended March 31, 2024, the Group's revenue was HK$269.02 million, an 84.1% increase year-on-year, with profit before tax reaching HK$37.52 million and profit for the year at HK$30.67 million Consolidated Statement of Profit or Loss Summary (HK$ Thousand) | Item | 2024 | 2023 | | :--- | :--- | :--- | | Revenue | 269,022 | 146,158 | | Cost of Sales | (34,729) | (24,924) | | **Gross Profit** | **234,293** | **121,234** | | Selling and Distribution Expenses | (159,450) | (90,837) | | General and Administrative Expenses | (35,490) | (32,421) | | **Profit Before Tax** | **37,519** | **1,160** | | Income Tax Expense | (6,845) | (663) | | **Profit for the Year** | **30,674** | **497** | [Consolidated Statement of Financial Position](index=3&type=section&id=Consolidated%20Statement%20of%20Financial%20Position) As of March 31, 2024, the Group's total assets were HK$218.81 million, total liabilities HK$40.60 million, and net assets increased to HK$178.21 million, demonstrating robust liquidity with net current assets of HK$97.52 million Consolidated Statement of Financial Position Summary (HK$ Thousand) | Item | March 31, 2024 | March 31, 2023 | | :--- | :--- | :--- | | **Non-current Assets** | **89,665** | **93,405** | | **Current Assets** | **129,146** | **96,007** | | Of which: Cash and Cash Equivalents | 69,844 | 41,044 | | **Total Assets** | **218,811** | **189,412** | | **Current Liabilities** | **31,627** | **26,138** | | **Non-current Liabilities** | **8,974** | **7,214** | | **Total Liabilities** | **40,601** | **33,352** | | **Net Assets** | **178,210** | **156,060** | [Notes to the Consolidated Financial Statements](index=5&type=section&id=Notes%20to%20the%20Consolidated%20Financial%20Statements) This section details the basis of financial statement preparation, application of new accounting standards, and provides in-depth analysis and disclosure of key items such as revenue, segments, taxation, earnings per share, and dividends, with the core business being retail and wholesale of health and personal care products as a single reportable segment [Changes in Accounting Policies](index=5&type=section&id=2.%20Application%20of%20new%20and%20revised%20HKFRS) This year, the Group adopted several new and revised HKFRSs, including retrospective adjustments for the abolition of the MPF offsetting mechanism, which had no material impact on prior period financial positions, with other revisions primarily affecting disclosure methods - The Group has adopted several new and revised Hong Kong Financial Reporting Standards for the first time, including definitions of accounting estimates and deferred tax related to a single transaction[15](index=15&type=chunk)[36](index=36&type=chunk) - In response to the abolition of the MPF offsetting mechanism in Hong Kong, the Group retrospectively implemented HKICPA guidance, changing the accounting treatment for long service payment obligations, resulting in a slight increase in general and administrative expenses and finance costs[41](index=41&type=chunk)[42](index=42&type=chunk)[44](index=44&type=chunk) [Revenue and Segment Reporting](index=10&type=section&id=4.%20Revenue%20and%20segment%20reporting) All Group revenue is derived from retail and wholesale of health and personal care products, forming a single reportable segment, with health supplements accounting for 95.5% of total revenue and consignment counters being the primary channel, growing 138.4% to 70.7% of sales - The Group has only one reportable and operating segment, which is the retail and wholesale of health and personal care products[28](index=28&type=chunk)[71](index=71&type=chunk) Revenue by Product Category (HK$ Thousand) | Product Category | 2024 | 2023 | YoY Change | | :--- | :--- | :--- | :--- | | Health Supplement Products | 256,941 | 141,400 | +81.7% | | Personal Care Products | 11,092 | 3,075 | +260.7% | | Honey and Pollen Products | 989 | 1,683 | -41.2% | | **Total** | **269,022** | **146,158** | **+84.1%** | Revenue by Sales Channel (HK$ Thousand) | Sales Channel | 2024 | 2023 | YoY Change | | :--- | :--- | :--- | :--- | | Specialty Stores | 43,546 | 39,890 | +9.2% | | Consignment Counters | 190,305 | 79,829 | +138.4% | | E-commerce | 20,583 | 17,921 | +14.9% | | Other Sales Channels | 14,588 | 8,518 | +71.3% | | **Total** | **269,022** | **146,158** | **+84.1%** | [Dividends](index=15&type=section&id=10.%20Dividends) The Board recommends a final dividend of HK$0.02 per ordinary share for the year ended March 31, 2024, totaling approximately HK$15.24 million, doubling last year's dividend, pending AGM approval - The Board recommended a final dividend of **HK$0.02 per share**, totaling **HK$15.24 million**, for the year ended March 31, 2024[107](index=107&type=chunk)[130](index=130&type=chunk) - The final dividend for 2023 was **HK$0.01 per share**, totaling **HK$7.62 million**[60](index=60&type=chunk)[107](index=107&type=chunk) [Management Discussion and Analysis](index=18&type=section&id=Management%20Discussion%20and%20Analysis) Management reviewed the operating environment and performance, noting significant revenue and profit growth driven by Hong Kong's tourism recovery, maintaining a robust financial position with ample liquidity and low gearing, and plans to enrich product portfolios, optimize OMO sales, and leverage AI for sustainable growth [Market Overview and Business Review](index=18&type=section&id=Market%20Overview%20and%20Business%20Review) Visitor arrivals in Hong Kong surged following the lifting of pandemic restrictions and promotional campaigns, stimulating the retail market, leading to the Group's revenue growing 84.1% to HK$269.02 million and profit reaching HK$30.67 million, though challenges like cross-border consumption trends persist - Total visitor arrivals in Hong Kong continuously increased by **715.0%** to approximately **40.81 million**, stimulating retail activity[113](index=113&type=chunk) - Group revenue increased by **84.1%**, primarily due to the recovery of Hong Kong's tourism industry, boosting tourist spending[89](index=89&type=chunk) - Management noted market challenges including macroeconomic uncertainties, increased cost pressures, and changes in local consumer behavior due to Hong Kong residents' cross-border consumption[66](index=66&type=chunk) [Financial Review](index=19&type=section&id=Financial%20Review) This year, cost of sales increased 39.3% with revenue, but gross margin improved to 87.1% due to optimized pricing; sales and distribution expenses rose 75.5% from higher consignment fees, and other income significantly decreased due to the absence of government subsidies, resulting in an annual profit of HK$30.67 million - Gross margin increased from **82.9% to 87.1%**, primarily due to optimized pricing policies based on market conditions[92](index=92&type=chunk) - Sales and distribution expenses increased by **75.5%**, mainly due to a **166.8%** rise in consignment expenses related to revenue growth[119](index=119&type=chunk) - Other income decreased by **71.8%**, primarily due to the non-recognition of government subsidies and landlord rental concessions in the current year[118](index=118&type=chunk) [Liquidity and Financial Resources](index=21&type=section&id=Liquidity%20and%20Financial%20Resources) The Group's financial position is robust, with total cash and time deposits of HK$75.36 million and a current ratio of 4.1 as of March 31, 2024, and a very low debt-to-equity ratio of 1.4%, while foreign exchange risks from JPY, AUD, and RMB are monitored without a hedging policy Liquidity and Capital Structure | Indicator | March 31, 2024 (HK$ Thousand) | March 31, 2023 (HK$ Thousand) | | :--- | :--- | :--- | | Net Current Assets | 97,519 | 69,869 | | Net Assets | 178,210 | 156,060 | | Current Ratio | 4.1 | 3.7 | | Debt-to-Equity Ratio | 1.4% | 1.9% | - The Group's foreign exchange risk primarily stems from sales and purchases denominated in **JPY, AUD, and RMB**, with no hedging policy currently in place, but regular monitoring is conducted[98](index=98&type=chunk) [Future Outlook and Prospects](index=23&type=section&id=Future%20Outlook%20and%20Prospects) Facing macroeconomic uncertainties, the Group is committed to long-term development by enriching its product portfolio through R&D innovation, optimizing its OMO sales network, and leveraging AI for customer analysis to enhance personalized shopping experiences and achieve sustainable growth - The Group will continue to enrich its product portfolio and focus on **R&D innovation** to maintain customer loyalty[104](index=104&type=chunk) - Plans include utilizing advanced technologies like **Artificial Intelligence (AI)** for customer preference analysis to support an **Online-Merge-Offline (OMO)** sales strategy, providing a unified shopping experience[132](index=132&type=chunk) - Will continuously optimize online and offline sales networks, including establishing physical stores in high-traffic areas and collaborating with reputable online platforms to deepen market penetration[146](index=146&type=chunk) [Corporate Governance and Other Information](index=24&type=section&id=Corporate%20Governance%20and%20Other%20Information) During the year, the company largely complied with the Corporate Governance Code, with a deviation regarding the Chairman and CEO roles being held by the same individual, for which the Board provided a reasonable explanation, and the annual results were reviewed by the Audit Committee and agreed upon by the auditors - The company deviated from the Corporate Governance Code's requirement for separation of Chairman and CEO roles; the Board believes the current Chairman, Mr. Choi Chi Fai, also serving as Co-CEO, is in the Group's best interest due to his industry knowledge and network, with sufficient safeguards for Board power balance[135](index=135&type=chunk)[149](index=149&type=chunk) - The Group's results for the year ended March 31, 2024, were reviewed by the Board's Audit Committee[138](index=138&type=chunk) - During the year, neither the company nor any of its subsidiaries purchased, sold, or redeemed its listed securities[134](index=134&type=chunk)

Financial Performance - Revenue for the six months ended September 30, 2023, was HKD 130,783,000, representing a 113.4% increase compared to HKD 61,292,000 in the same period of 2022[4] - Gross profit for the same period was HKD 113,675,000, up from HKD 51,117,000, indicating a significant improvement in profitability[4] - The company reported a profit before tax of HKD 19,258,000, compared to a loss of HKD 433,000 in the previous year[4] - Net profit for the period was HKD 15,173,000, a turnaround from a loss of HKD 365,000 in the prior year[4] - Basic earnings per share for the period was HKD 1.99, compared to a loss per share of HKD 0.05 in the same period last year[6] - The group reported a profit attributable to owners of the company of HKD 15,173,000 for the six months ended September 30, 2023, compared to a loss of HKD 365,000 in the same period of 2022[49] - The group recorded a profit of HKD 15,173,000 for the period, a significant turnaround from a loss of HKD 365,000 in the previous year[65] Revenue Breakdown - Revenue from health supplement products reached HKD 125,092,000, a substantial increase of 111% from HKD 59,267,000 in the previous year[28] - Revenue from health supplement products rose by 111.1% to HKD 125,092,000, while personal care products increased by 307.5% to HKD 5,167,000; however, honey and pollen products decreased by 30.8% to HKD 524,000[70] - Sales from specialty stores increased by 11.4% to HKD 22,273,000, and revenue from consignment counters surged by 208.1% to HKD 94,952,000; e-commerce revenue slightly decreased by 2.5% to HKD 7,758,000[73] Assets and Liabilities - Total assets as of September 30, 2023, were HKD 172,160,000, an increase from HKD 163,274,000 as of March 31, 2023[8] - Current assets increased to HKD 119,400,000 from HKD 96,007,000, reflecting improved liquidity[8] - The total equity increased to HKD 162,796,000 from HKD 156,060,000, showing growth in shareholder value[10] - Accounts receivable increased to HKD 24,281,000 as of September 30, 2023, from HKD 16,772,000 as of March 31, 2023[53] - The group’s accounts payable rose to HKD 15,460,000 as of September 30, 2023, compared to HKD 12,202,000 as of March 31, 2023[56] - The total outstanding bank borrowings amounted to HKD 2,694,000 as of September 30, 2023, down from HKD 2,898,000 as of March 31, 2023[82] - The debt-to-equity ratio was 1.7% as of September 30, 2023, indicating a reasonable level of capital leverage[82] Cash Flow - Cash generated from operating activities was HKD 20,106,000, a recovery from a cash outflow of HKD 1,640,000 in the same period last year[17] - The company’s cash and cash equivalents rose to HKD 48,547,000 from HKD 41,044,000, indicating a stronger cash position[8] - The company’s cash and cash equivalents increased to HKD 48,547,000 from HKD 38,794,000 year-over-year, reflecting a positive cash flow trend[19] - The group incurred a net loss of HKD 1,651,000 from other losses for the six months ended September 30, 2023, compared to a loss of HKD 1,226,000 in 2022[38] - The company reported a net cash outflow from investing activities of HKD 5,602,000, compared to HKD 8,043,000 in the previous year, suggesting a reduction in capital expenditures[17] - The company’s financing activities resulted in a net cash outflow of HKD 6,747,000, slightly improved from HKD 7,305,000 in the previous year, indicating better management of financing costs[19] Market and Growth Strategy - The company plans to continue expanding its market presence and investing in new product development to sustain growth[4] - The company plans to continue expanding its product offerings in health and personal care, focusing on brand development and distribution[21] - The group plans to continue carefully selecting suitable locations for specialty stores and other sales channels to enhance brand visibility among target customers[65] - The company aims to diversify its product portfolio and optimize pricing strategies to enhance operational performance[91] - The group plans to expand its online and offline sales network to capture market share in a high financing cost environment[91] Operational Highlights - The company experienced a significant increase in sales through consignment counters, which rose to HKD 94,952,000 from HKD 30,823,000, highlighting a successful sales strategy[28] - The number of stores increased to 18 and consignment counters to 60 as of September 30, 2023, compared to 17 stores and 60 counters as of March 31, 2023[65] - The employee count increased to 201 as of September 30, 2023, up from 189 on March 31, 2023[88] Governance and Compliance - The company has adhered to the corporate governance code, with a noted exception regarding the dual role of the chairman and CEO[105] - The audit committee has reviewed and supervised the group's financial reporting system and internal control procedures during the reporting period[109] - The company has adopted a standard code for directors' securities trading, with all directors confirming compliance throughout the reporting period[107] - The company plans to appoint new independent non-executive directors within three months to comply with listing rules following the recent vacancy[106] Dividends and Shareholder Information - The group did not declare an interim dividend for the six months ended September 30, 2023, consistent with the previous year[47] - The company expressed gratitude to shareholders, business partners, and employees for their ongoing support and contributions[111] - As of September 30, 2023, Beatitudes International Ltd. held approximately 55.82% of the company's shares[96] Economic Environment - The group experienced a significant rebound in business performance due to the return of mainland Chinese tourists, despite facing economic uncertainties in Hong Kong[91] - The overall retail sales in Hong Kong increased by 16.0% from April to September 2023 compared to the same period last year, driven by the recovery of tourism[64] - The number of visitors to Hong Kong surged to approximately 18,907,000 from about 238,000 in the same period last year, significantly boosting retail activity[64]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Ausupreme International Holdings Limited 澳 至 尊 國 際 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：2031） 截至2023年9月30日止六個月 未經審核中期業績公告 業績 澳至尊國際控股有限公司（「本公司」）之董事（「董事」）會（「董事會」）提呈本公司及其附屬 公司（統稱「本集團」）截至2023年9月30日止六個月（「本期間」）之未經審核簡明綜合業績， 連同有關之比較數字如下： 簡明綜合損益及其他全面收益表 截至2023年9月30日止六個月 截至9月30日止六個月 2023年 2022年 附註 千港元 千港元 （未經審核） （未經審核） ...

Company Overview - The company specializes in high-quality health supplements and personal care products, certified by multiple international standards, including TGA and GMP[12]. - The company has received recognition as a "Hong Kong Excellent Brand" and has been acknowledged as a quality merchant by the Hong Kong Tourism Board for 15 consecutive years[12]. - The business has shown steady growth, supported by strong market acceptance in Hong Kong and across Asia[12]. Market Presence and Sales Strategy - As of March 31, 2023, the company operates 17 specialty stores and 60 consignment counters in Hong Kong, Macau, and Singapore, establishing a solid foundation in the region[19]. - The company has expanded its online sales strategy, enhancing its official website and custom app to improve customer experience and loyalty[15]. - The company has partnered with various e-commerce platforms, including HKTVmall and Tmall, significantly increasing market penetration[16]. - The introduction of the "Omnichat" promotional software has improved customer interaction and communication, allowing for precise promotional targeting[15]. - The company has established a cross-border e-commerce experience store in Shenzhen, further enhancing its market presence[19]. Social Responsibility and Community Engagement - The company is committed to social responsibility, actively participating in community initiatives and promoting healthy lifestyles[26]. - The company actively promotes sports activities among employees and their families, contributing to work-life balance[34]. - The company has established a karate dojo to promote the sport and has achieved notable results in local competitions, including championships in various categories[34]. - The company emphasizes social responsibility and has been involved in various charitable activities, including donations to support underprivileged students[41]. - The company supports anti-drug initiatives and has participated in events to educate youth about drug prevention[36]. - The company has organized various employee engagement activities, such as movie screenings and concerts, to foster a positive workplace culture[42]. - The company has been involved in community sports projects to encourage healthy lifestyles and support local sports development[38]. - The company has provided financial assistance to economically disadvantaged students and participated in educational seminars[51]. - The company’s chairman has been actively involved in community service and youth education initiatives, sharing experiences and insights[41]. - The company has sponsored local karate competitions and supported the Hong Kong Karate Association in organizing events[34]. - The company has a commitment to nurturing future leaders through educational support and community engagement[41]. Financial Performance - The company reported a revenue increase of 13.5% to HKD 146,158,000 for the fiscal year ending March 31, 2023, compared to the previous year[103]. - The company achieved a consolidated profit of HKD 497,000, recovering from a loss of HKD 843,000 in the previous year[103]. - The board proposed a final cash dividend of HKD 0.01 per share to reward shareholders for their support[103]. - Revenue from health supplement products increased by 15.3% to HKD 141,400,000, while personal care products and honey/pollen products saw declines of 26.3% and 10.4%, respectively[117]. - Sales through specialty stores and consignment counters increased by 7.8% to HKD 39,890,000 and 27.0% to HKD 79,829,000, respectively, driven by the influx of travelers from mainland China[119]. - The group's gross profit margin slightly improved to 82.9% from 81.7% in the previous year, despite a 5.7% increase in cost of sales to HKD 24,924,000[120]. - Other income rose by 107.9% to HKD 4,238,000, primarily due to increased government subsidies and bank interest income[120]. - The income tax expense for the year was HKD 663,000, a shift from an income tax credit of HKD 2,123,000 in the previous year, reflecting the transition from a loss to a profit[124]. Future Outlook and Strategic Initiatives - The company plans to launch new diversified products to meet the varying needs of target customers[105]. - Strategic partnerships have been established with suppliers and businesses to expand both online and physical sales networks[105]. - The company aims to recruit and build a dynamic team in various regions to support its diversified business development[105]. - The group plans to expand its product portfolio to cater to changing customer preferences and enhance customer health[138]. - The integration of online and offline sales remains a key focus, aiming to improve customer experience and loyalty[140]. - The group will continue to streamline inventory levels and optimize its physical store network to enhance operational efficiency[138]. - The company is expanding its market presence in Southeast Asia, aiming to increase market share by 30% in the region over the next two years[154]. - A strategic acquisition of a local health food brand is in progress, which is anticipated to enhance the product portfolio and increase market penetration[154]. - Investment in technology development is set at HKD 50 million, aimed at improving online sales channels and customer engagement platforms[154]. - The company plans to enhance its marketing strategies, allocating 10% of revenue towards digital marketing initiatives to boost brand visibility[154]. - The management team has emphasized a commitment to sustainability, with plans to reduce carbon emissions by 15% over the next three years[154]. Governance and Corporate Structure - The company has a strong governance structure with over 40% of the board members being independent non-executive directors[170]. - The board consists of seven members, including the chairman and co-CEOs, ensuring a balance of executive and independent oversight[170]. - The company has adopted a standard code for securities trading by directors, confirming compliance throughout the year[165]. - The management team is led by a finance director with over 20 years of experience in accounting services[160]. - The company emphasizes accountability and risk management as part of its corporate governance practices[163]. - The independent non-executive directors contribute significant business and financial expertise to the board[171]. - The company has appropriate insurance coverage for potential legal claims against directors[173]. - The finance team is responsible for overseeing corporate financing, treasury, financial reporting, and tax matters[157]. - The company has established various board committees to delegate responsibilities effectively[166]. - The management is tasked with executing the business plans and strategies adopted by the board[166]. - The board held 4 meetings during the year, including the approval of the audited consolidated financial statements for the year ended March 31, 2022, and the unaudited consolidated financial statements for the six months ended September 30, 2022[175]. - All directors attended 100% of the board meetings, with each director present for all 4 meetings[178]. - The audit committee held 3 meetings during the year, including the review and approval of the audited consolidated financial statements for the year ended March 31, 2022[185]. - The audit committee consists of three independent non-executive directors, ensuring compliance with corporate governance codes and listing rules[181]. - The remuneration committee was established on July 20, 2016, and includes two independent non-executive directors and one executive director[187]. - The company encourages all directors to participate in training courses, with costs covered by the company, to enhance their understanding of corporate governance responsibilities[174]. - The chairman and co-CEO's dual role is deemed in the best interest of the group, with all major decisions made after consulting the entire board[179]. - The company has established three committees under the board: audit committee, remuneration committee, and nomination committee, to oversee specific aspects of the company's affairs[180]. - The audit committee's responsibilities include monitoring the integrity of financial statements and reviewing risk management and internal control systems[183]. - The company held one annual general meeting and one special general meeting during the year, with full attendance from all directors[178]. - The Compensation Committee held 3 meetings during the year to review and approve the remuneration proposals for directors and senior management[190]. - Attendance records for the Compensation Committee meetings show that all directors attended all 3 meetings[191]. - The Nomination Committee was established on July 20, 2016, and includes two independent non-executive directors and one executive director[192]. - The Nomination Committee held 2 meetings during the year to evaluate the board's structure, size, and composition[196]. - Attendance records for the Nomination Committee meetings indicate full attendance by all directors[197]. - The Nomination Committee's responsibilities include reviewing and approving compensation arrangements for directors dismissed for misconduct[193]. - The Nomination Committee assesses the independence of independent non-executive directors[194]. - The company emphasizes the importance of diversity in the board's composition, considering various factors such as gender and professional background[199]. - The company aims to ensure that candidates possess relevant skills, knowledge, and experience related to its business[199]. - The Nomination Committee follows a structured process for nominating candidates for board appointments or shareholder elections[198].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部份內容而 產生或因依賴該等內容而引致的任何損失承擔任何責任。 Ausupreme International Holdings Limited 澳 至 尊 國 際 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：2031） 截至2023年3月31日止年度 全年業績公佈 澳至尊國際控股有限公司（「本公司」）董事（「董事」）會（「董事會」）提呈本公司及其附屬公 司（統稱為「本集團」）截至2023年3月31日止年度（「本年度」或「年內」）之綜合業績，連同 截至2022年3月31日止年度（「2022年度」）之比較數據。 綜合損益及其他全面收益表 截至2023年3月31日止年度 截至3月31日止年度 2023年 2022年 附註 千港元 千港元 收益 4 146,158 128,726 銷售成本 (24,924) (23,580) ...

Financial Performance - Revenue for the six months ended September 30, 2022, was HKD 61,292,000, a decrease of 3.5% from HKD 63,392,000 in the same period of 2021[4] - Gross profit for the same period was HKD 51,117,000, down from HKD 52,500,000, reflecting a decline of 2.6%[4] - The company reported a loss before tax of HKD 433,000 compared to a profit of HKD 51,000 in the previous year[4] - The net loss for the period was HKD 365,000, compared to a loss of HKD 209,000 in the prior year, indicating a 74.9% increase in losses[4] - The company reported a total revenue of HKD 61,292 thousand for the six months ended September 30, 2022, a decrease of 3.3% from HKD 63,392 thousand in the same period of 2021[32] - Revenue from health supplement products was HKD 59,267 thousand, while personal care products and honey & pollen products generated HKD 1,268 thousand and HKD 757 thousand, respectively[32] - The group reported a net loss of HKD 365,000 attributable to owners for the six months ended September 30, 2022, compared to a loss of HKD 209,000 for the same period in 2021[57] - The group recorded a loss attributable to owners of HKD 365,000, compared to a loss of HKD 209,000 in the same period last year, primarily due to foreign exchange losses and reduced revenue from the Macau division[88] - The basic loss per share for the six months ended September 30, 2022, was HKD 0.05, compared to HKD 0.03 for the same period last year[100] Assets and Liabilities - Total assets as of September 30, 2022, were HKD 127,634,000, a slight decrease from HKD 130,837,000 as of March 31, 2022[10] - The company's net asset value decreased to HKD 155,688,000 from HKD 166,565,000, representing a decline of 6.5%[12] - The company’s cash and cash equivalents decreased to HKD 38,794,000 from HKD 56,156,000, a decline of 30.9%[10] - The company’s inventory increased to HKD 20,197,000 from HKD 15,098,000, representing a rise of 33.8%[10] - Accounts receivable as of September 30, 2022, amounted to HKD 8,144 million, an increase of 11.4% from HKD 7,312 million as of March 31, 2022[66] - Total liabilities as of September 30, 2022, were HKD 11,294 million, a decrease of 16% from HKD 13,394 million as of March 31, 2022[71] - The company's issued and fully paid share capital remained at HKD 7,620 million with 762 million shares as of September 30, 2022, unchanged from March 31, 2022[76] Cash Flow and Investments - The operating cash flow before tax was a loss of HKD 433 thousand for the six months ended September 30, 2022, compared to a profit of HKD 51 thousand in the same period of 2021[19] - The net cash used in operating activities was HKD 1,640 thousand for the six months ended September 30, 2022, a significant decline from HKD 9,758 thousand in the previous year[19] - The company reported a net cash outflow from investing activities of HKD 8,043 thousand for the six months ended September 30, 2022, compared to an inflow of HKD 22,688 thousand in the same period of 2021[19] - The company’s cash and cash equivalents decreased to HKD 38,794 thousand as of September 30, 2022, down from HKD 85,239 thousand at the same time in 2021[22] - The company incurred a net foreign exchange loss of HKD 1,226,000 for the six months ended September 30, 2022, compared to a gain of HKD 258,000 in the previous year[44] - The group recognized government subsidies of approximately HKD 2,502,000 under the Hong Kong government's employment support scheme for the six months ended September 30, 2022[40] - Other income for the six months ended September 30, 2022, included bank interest income of HKD 147,000, government subsidies of HKD 2,505,000, and rental concessions of HKD 535,000[39] Operational Highlights - The group has one operating segment, which is the retail and wholesale of health and personal care products[37] - The group has 18 specialty stores and 63 consignment counters as of September 30, 2022, with 12 consignment counters still closed due to COVID-19 restrictions[89] - The group is actively reviewing and enhancing its business plans to adapt to the changing business environment and mitigate risks posed by the COVID-19 pandemic[88] - The overall retail sales in Hong Kong recorded a slight growth of 2.1% during the period, but the positive impact of government consumption voucher schemes is diminishing[85] Expenses and Dividends - Other comprehensive expenses for the period totaled HKD 3,257,000, compared to HKD 1,527,000 in the previous year, reflecting a significant increase of 113.4%[7] - The company paid dividends amounting to HKD 7,620 thousand during the period[17] - The group did not declare an interim dividend for the six months ended September 30, 2022, consistent with the previous year[55] - Sales and distribution expenses slightly increased by 0.4% to HKD 39,330,000, while general and administrative expenses rose by 2.8% to HKD 14,234,000[97] Corporate Governance - The audit committee consists of three independent non-executive directors responsible for reviewing the financial reporting system and internal control procedures[137] - The company has complied with all provisions of the corporate governance code, except for the separation of the roles of chairman and CEO[132] - The company has maintained a public float of at least 25% of its total issued shares throughout the reporting period[136] Employee and Market Insights - The company employed 167 staff as of September 30, 2022, an increase from 158 staff as of March 31, 2022[109] - The unemployment rate in Hong Kong decreased from 3.9% to 3.8% between July-September 2022 and August-October 2022, indicating a continued improvement in the labor market[112] - The company is implementing stricter cost control measures and reallocating physical store locations and manpower to enhance operational efficiency amid economic uncertainties[112]

Financial Performance - AUSupreme reported a revenue increase of 15% year-over-year, reaching HKD 500 million for the fiscal year 2021-22[12] - The company achieved a gross profit margin of 40%, reflecting improved operational efficiency compared to the previous year[12] - The company reported a net profit of HKD 100 million, a 10% increase from the previous fiscal year[12] - For the fiscal year ending March 31, 2022, the company's revenue was HKD 128,726,000, representing a 25.1% increase from HKD 102,907,000 in 2021[67] - The company recorded a loss of HKD 843,000 for the year, compared to a profit of HKD 3,844,000 in the previous year, primarily due to the absence of COVID-19 related government subsidies and reduced rental income[67] - Revenue from health supplement products increased by 25.4% to HKD 122,675,000, accounting for 95.3% of total revenue[70] Market Expansion and Strategy - AUSupreme plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share over the next two years[12] - Future guidance estimates a revenue growth of 20% for the upcoming fiscal year, driven by new product launches and market expansion[12] - The company aims to continue expanding its market presence in Asia, focusing on becoming a leading health brand[26] - The company emphasizes a diversified market strategy, particularly in local and cross-border e-commerce[27] - The company is exploring potential acquisition opportunities in the health and wellness sector to diversify its product offerings[12] Product Development and Innovation - The company is investing HKD 50 million in new product development, focusing on health supplements and wellness products[12] - The company is focused on developing online sales channels and maintaining its enterprise resource planning systems[108] - The company is exploring new product development and technological advancements to enhance its market position[116] Online Sales and E-commerce - The company has accelerated online sales development, launching a new official website and a customized app to enhance customer experience[27] - The online shopping experience was enhanced with a new official website, focusing on e-commerce and social media platforms to boost sales and brand awareness[61] - The company plans to invest more resources into interest-based e-commerce, particularly through platforms like Douyin, to leverage their large user base and recommendation technology[94] Corporate Social Responsibility - The company is committed to social responsibility, actively engaging in community support initiatives and educational programs[28] - The company has been involved in anti-drug campaigns, promoting a healthy lifestyle within the community[29] - The company remains committed to social contributions, including donations of health supplies and support for educational initiatives during the pandemic[61] Governance and Management - The company has a robust governance structure with independent directors providing oversight and strategic guidance[112] - The board consists of seven directors, with independent non-executive directors accounting for over 40% of the board members[125] - The company has established a clear framework for the appointment and evaluation of board members to align with corporate strategy[150] Awards and Recognition - The company has received multiple awards and certifications, including the "Hong Kong Excellent Brand" and "Outstanding Listed Company Award," highlighting its market value and industry recognition[41][46] - The company has been recognized for its commitment to sustainable development and corporate social responsibility, receiving accolades such as the "Sustainable Supply Chain Leader" award[48] - The company has been acknowledged as a leading brand in the health supplement industry, receiving the "Asia Excellent Brand" award for its innovative practices[51] Challenges and Risks - The company anticipates continued volatility in the business environment due to ongoing pandemic effects and geopolitical tensions, but expects to benefit from new government consumption voucher programs[62] - The company is prepared for business development in the upcoming years, leveraging its solid foundation[96] - Management acknowledges the operational dependency on third parties may lead to service deterioration or errors[200] - Potential risks include damage to reputation, business interruptions, and financial losses[200] Employee Engagement and Development - The company has established a healthy and vibrant work environment, encouraging employee participation in physical activities, which has been recognized by the "Corporate Together Action Award" program[58] - The company has maintained a strong focus on employee training and development, achieving the "Super MD" status for ten consecutive years[46] - The company has a commitment to employee training and development, as evidenced by its mentorship programs[107]

Financial Performance - Revenue for the six months ended September 30, 2021, was HKD 63,392,000, an increase of 54% compared to HKD 41,190,000 for the same period in 2020[6] - Gross profit for the same period was HKD 52,500,000, up from HKD 33,713,000, reflecting a gross margin improvement[6] - Operating profit decreased to HKD 228,000 from HKD 3,385,000, indicating challenges in operational efficiency[6] - The company reported a loss attributable to owners of the company of HKD 260,000, compared to a profit of HKD 2,810,000 in the previous year[6] - The company incurred a loss of HKD 209,000 during the six months ended September 30, 2021, compared to a profit of HKD 2,810,000 in the same period of 2020[12] - The group reported total revenue of HKD 63,392,000 for the six months ended September 30, 2021, compared to HKD 41,190,000 for the same period in 2020, representing a year-over-year increase of 54%[25] - Revenue from health supplements reached HKD 60,723,000, up from HKD 39,228,000 in the previous year, indicating a growth of 55%[26] - The group generated other income of HKD 484,000, significantly down from HKD 9,193,000 in the prior period, reflecting a decrease of approximately 95%[32] - The group’s pre-tax profit was impacted by a decrease in bank interest income, which fell to HKD 77,000 from HKD 698,000 year-over-year, a decline of 89%[32] - The total cost of inventory for the period was HKD 10,892,000, an increase from HKD 7,477,000 in the same period last year, representing a rise of 46%[36] - The group’s total tax expense for the six months ended September 30, 2021, was HKD 260,000, slightly down from HKD 261,000 in the prior year[38] Assets and Liabilities - Total assets as of September 30, 2021, were HKD 170,463,000, down from HKD 179,905,000 as of March 31, 2021[10] - Net asset value decreased to HKD 167,080,000 from HKD 176,227,000, indicating a decline in shareholder equity[10] - Current liabilities increased to HKD 31,040,000 from HKD 22,266,000, reflecting higher operational obligations[10] - The company’s total liabilities increased to HKD 12,121,000 as of September 30, 2021, from HKD 9,988,000 as of March 31, 2021[54] - The company’s receivables amounted to HKD 9,405,000 as of September 30, 2021, down from HKD 11,109,000 as of March 31, 2021[48] - The fair value of equity investments classified as other comprehensive income decreased to HKD 4,222,000 as of September 30, 2021, from HKD 5,506,000 as of March 31, 2021[45] - The company’s accounts payable increased significantly to HKD 4,120,000 as of September 30, 2021, from HKD 1,700,000 as of March 31, 2021[54] Cash Flow and Liquidity - The company’s cash and cash equivalents stood at HKD 85,239,000, an increase from HKD 59,987,000, indicating improved liquidity[10] - The net cash generated from operating activities was HKD 9,758,000 for the six months ended September 30, 2021, a decrease from HKD 15,734,000 in the prior year[15] - The company’s operating cash flow before changes in working capital was HKD 7,206,000, down from HKD 11,856,000 in the previous year[15] - The company reported a significant increase in cash and cash equivalents, totaling HKD 85,239,000 at the end of the period, compared to HKD 63,561,000 a year earlier, representing a growth of approximately 34%[15] Strategic Outlook - The company plans to focus on new product development and market expansion strategies in the upcoming periods[6] - Future outlook remains cautious due to market volatility and operational challenges faced during the reporting period[6] - The company plans to continue expanding its market presence in Hong Kong and enhance its product offerings in the health and personal care sector[17] - The group plans to strategically expand its physical sales network into prime retail locations and hire professional health consultants to enhance customer experience and drive sales[87] - The group is actively implementing various marketing initiatives, including attractive promotional activities and social media engagement, to attract new customers and improve customer loyalty[87] - The management acknowledges that the pandemic and other macroeconomic variables may affect the speed of market recovery but remains committed to providing quality products and services[87] Shareholder Information - The company did not declare an interim dividend for the six months ended September 30, 2021, compared to no dividend declared in 2020[42] - As of September 30, 2021, Beatitudes International Ltd. holds 425,340,000 shares, representing approximately 55.82% of the company's issued share capital[93] - Mr. Gao holds 89,225,000 shares, accounting for about 11.71% of the company's equity as of September 30, 2021[94] - Following a placement agreement, Beatitudes' shareholding decreased from 562,500,000 shares (approximately 73.82%) to 425,340,000 shares (approximately 55.82%) after the completion of the placement on September 13, 2021[93] - The average number of issued ordinary shares remained constant at 762,000,000 for both periods[43] - A total of 137,160,000 shares were successfully placed to 21 subscribers, resulting in 247,435,000 shares (approximately 32.47% of the company's issued share capital) held by public shareholders[105] - As of September 30, 2021, public holdings accounted for no less than 25% of the total issued shares[107] Corporate Governance - The company has complied with all provisions of the corporate governance code during the reporting period, except for the exception regarding the roles of the chairman and CEO[101] - The audit committee, composed of three independent non-executive directors, is responsible for reviewing and supervising the financial reporting system and internal control procedures of the group[108]

Financial Performance - AUSupreme reported a revenue of HKD 200 million for the fiscal year 2020-2021, representing a 15% increase compared to the previous year[22]. - The company achieved a gross profit margin of 40%, up from 35% in the prior year, indicating improved operational efficiency[22]. - The group’s revenue for the year ended March 31, 2021, was HKD 102,907,000, a decrease of 51.1% from HKD 210,543,000 in 2020[66]. - The profit attributable to the company's owners for the year was HKD 3,844,000, down 68.1% from HKD 12,047,000 in 2020[68]. - Revenue from health supplement products decreased by 49.8% to HKD 97,846,000, compared to HKD 194,770,000 in 2020[70]. - Revenue from personal care products fell by 74.7% to HKD 3,240,000, down from HKD 12,811,000 in 2020[70]. - Revenue from consignment counters dropped by 70.8% to HKD 47,382,000, compared to HKD 162,279,000 in 2020[74]. - E-commerce revenue increased by 74.7% to HKD 16,563,000, up from HKD 9,481,000 in 2020[74]. - Basic earnings per share for the year were HKD 0.50, down from HKD 1.60 in 2020[78]. Market Expansion and Product Development - AUSupreme plans to launch three new products in the next quarter, targeting a market expansion of 20% in the health supplement sector[22]. - The company is exploring potential acquisitions to expand its market presence in Southeast Asia, with a target completion date by Q3 2022[22]. - The company aims to expand its market presence both domestically and internationally, striving to build a well-known health brand in Asia[30]. - New product launches are anticipated to contribute an additional $C million in revenue, with a focus on expanding the health supplement product line[101]. - Market expansion plans include entering E new markets, with an expected increase in market share of F% within the next year[101]. - The company is exploring market expansion opportunities in international regions, targeting a growth rate of DD% in those markets[112]. Operational Efficiency and Cost Management - AUSupreme's operating expenses decreased by 5% due to cost-cutting measures and improved supply chain management[22]. - Total sales and distribution expenses decreased by 47.1% to HKD 73,620,000, compared to HKD 139,173,000 in 2020[75]. - Operational efficiency improvements are expected to reduce costs by GG%, contributing to overall profitability[112]. Sustainability and Social Responsibility - The company emphasized its commitment to sustainability, with plans to reduce carbon emissions by 25% over the next five years[22]. - The company has maintained a commitment to social responsibility, providing sufficient protective equipment and health products to employees during the COVID-19 pandemic[35]. - The management team emphasized a commitment to sustainability and corporate social responsibility initiatives, which are expected to resonate with consumers and drive brand loyalty[101]. - The board's report includes a commitment to environmental sustainability, aiming to minimize environmental impact through resource conservation and waste reduction policies[200]. Marketing and Sales Strategy - The company has implemented new marketing strategies, resulting in a 30% increase in online sales channels[22]. - The company has expanded its online sales strategy, partnering with various e-commerce platforms including HKTVmall, Tmall, JD.com, and Shopee, significantly increasing market penetration[31]. - The company focuses on community marketing and short video marketing to adapt to market changes and consumer psychology, aiming to create new momentum for development[60]. - The group plans to leverage digital technology and social media for marketing, including live streaming and engaging key opinion consumers (KOCs) to enhance customer experience[92]. Corporate Governance - The management team emphasized the importance of corporate governance and accountability in driving shareholder value[117]. - The board of directors includes a diverse range of expertise, with over 40% of members being independent non-executive directors, ensuring effective oversight[123]. - The audit committee is responsible for monitoring the integrity of the company's financial statements and reviewing significant judgments made in financial reporting[137]. - The company has established three committees under the board: the audit committee, remuneration committee, and nomination committee, to oversee specific aspects of the company's affairs[134]. - The board believes that the current structure, with Mr. Tsai as both chairman and co-CEO, serves the best interests of the group[133]. Employee and Operational Metrics - The group employed 164 staff as of March 31, 2021, a decrease from 201 in 2020[88]. - The company has a strong commitment to employee safety and health, implementing emergency measures during the pandemic to ensure operational continuity[35]. - The company has adopted a hybrid sales model combining online and offline strategies to adapt to changing market conditions due to the pandemic[31]. Awards and Recognition - The company has been recognized with multiple awards, including the "Hong Kong Excellent Brand" and "Parents' Favorite Supplement Brand" for its quality products[39]. - The company has received multiple awards for its brand image and product quality, enhancing its reputation in the health supplement industry[101]. - The company has received multiple awards recognizing its excellence in brand development and service quality, reinforcing its reputation in the health food industry[44][45][54].

Financial Performance - For the six months ended September 30, 2020, AUSupreme reported revenue of HKD 41,190,000, a decrease of 66.8% compared to HKD 124,006,000 for the same period in 2019[8]. - Gross profit for the same period was HKD 33,713,000, down 68.4% from HKD 106,698,000 year-over-year[8]. - Operating profit decreased to HKD 3,385,000, a decline of 70.8% compared to HKD 11,603,000 in the previous year[8]. - Profit attributable to owners of the company was HKD 2,810,000, down 68.5% from HKD 8,922,000 in the prior year[8]. - The company reported total assets of HKD 182,809,000 as of September 30, 2020, a decrease from HKD 190,821,000 as of March 31, 2020[11]. - Net assets attributable to owners of the company were HKD 176,368,000, down from HKD 181,666,000 at the end of the previous fiscal year[11]. - The company’s basic and diluted earnings per share for the period were HKD 0.37, compared to HKD 1.19 in the same period last year[8]. - Other comprehensive income for the period was HKD 2,322,000, down from HKD 8,898,000 in the prior year[8]. - The total comprehensive income for the period was HKD 2,322,000, after accounting for a foreign exchange loss of HKD (505,000)[13]. - The company's profit attributable to owners for the six months ended September 30, 2020, was HKD 2,810,000, a decrease of 68.5% compared to HKD 8,922,000 for the same period in 2019[47]. - Basic earnings per share for the period were HKD 0.37, down from HKD 1.19 in 2019, calculated based on the number of shares issued of 762,000,000[76]. Revenue Breakdown - Total revenue for the six months ended September 30, 2020, was HKD 41,190,000, a decrease of 66.8% compared to HKD 124,006,000 for the same period in 2019[32]. - Revenue from specialty stores was HKD 14,882,000, down 14.6% from HKD 17,423,000 in 2019[32]. - Revenue from consignment counters dropped significantly to HKD 17,220,000 from HKD 99,082,000, representing a decline of 82.6%[32]. - E-commerce revenue increased to HKD 7,304,000, up 110.6% from HKD 3,467,000 in the previous year[32]. - Other sales channels generated HKD 1,784,000, down 55.8% from HKD 4,034,000 in 2019[32]. - Revenue from health supplement products decreased by 65.7% to HKD 39,228,000, while personal care products and honey and pollen products saw declines of 86.4% and 50.1%, respectively[68]. Cash Flow and Investments - For the six months ended September 30, 2020, the net cash generated from operating activities was HKD 15,734,000, a decrease of 15.1% compared to HKD 18,490,000 for the same period in 2019[16]. - The net cash used in investing activities was HKD (21,000) for the six months ended September 30, 2020, compared to HKD 23,000 in the same period of 2019[16]. - The net cash used in financing activities was HKD (7,103,000), slightly improved from HKD (7,258,000) in the previous year[16]. - The total cash and cash equivalents increased by HKD 8,610,000, ending at HKD 63,561,000 as of September 30, 2020, compared to HKD 131,030,000 at the end of the same period in 2019[16]. - The cash and cash equivalents at the beginning of the period were HKD 54,935,000, compared to HKD 119,775,000 at the beginning of the same period in 2019[16]. Liabilities and Equity - Total liabilities increased to HKD 159,483,000, compared to HKD 152,280,000 as of March 31, 2020[11]. - The total liabilities as of September 30, 2020, were HKD 6,076,000, compared to HKD 12,874,000 as of March 31, 2020, indicating a significant reduction[54]. - The company had a total issued share capital of HKD 7,620,000 as of September 30, 2020, unchanged from the previous period[56]. - The company recognized contract liabilities of HKD 591,000 as of September 30, 2020, an increase from HKD 426,000 as of March 31, 2020, indicating growth in customer prepayments[54]. - As of September 30, 2020, the total equity attributable to owners of the company was HKD 176,368,000, down from HKD 181,666,000 as of March 31, 2020[13]. Operational Impact - The number of visitors to Hong Kong dropped by 99.7% year-on-year due to COVID-19 travel restrictions, severely impacting the retail environment[62]. - The ongoing COVID-19 pandemic has negatively impacted the company's operations, with uncertainty regarding the full extent and duration of its financial effects[105]. - The financial impact of the COVID-19 outbreak on the overall financial condition of customers in Hong Kong and mainland China remains unclear[105]. - The group operated 15 specialty stores and 81 consignment counters as of September 30, 2020, with 14 counters temporarily closed due to COVID-19[63]. - The management plans to focus on developing e-commerce to enhance online sales and allocate more resources to sales and marketing on e-commerce platforms and social media[90]. Corporate Governance and Shareholding - The company has complied with all provisions of the corporate governance code, except for the separation of roles between the chairman and the CEO, which are held by Mr. Cai Zhihui[110]. - The public shareholding ratio has decreased to approximately 14.47%, below the minimum requirement of 25% as per listing rules[115]. - A major shareholder holds 89,225,000 shares, representing about 11.71% of the total issued share capital[115]. - The company is considering various feasible options to address the insufficient public shareholding issue and has submitted proposals to the stock exchange[115]. - As of September 30, 2020, the major shareholders Beatitudes International Ltd. and Gao Yuan hold 73.82% and 11.71% of the company's shares, respectively, with Beatitudes owning 562,500,000 shares[100].